Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

DOI Full Paper Access

62

Citations

28

References

2020

Year

Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Xiao Cheng, Huan Wang, Lisong Teng, Hui Zhou,

Abstract

ClinicalTrials.gov, NCT02937116 . Registered 8 October 2016.

References

	Year	Citations

Page 1